European height and weight growth charts commonly extend from the 3rd to the 97th centile, whereas in North America the extremes are usually the 5th and 95th centiles. There is no good reason for the difference, and neither chart is particularly usefil for screening owing to the high false positive rate associated with a cut off based on the lowest centile. The World Health Organisation's international growth reference uses cut offs based on standard deviation scores rather than centiles, which are more suitable for the extremes of growth status seen in the developing world. This chart, however, is incompatible with charts based on centiles. Here a unified growth chart is proposed: it has nine rather than seven centiles, and they are spaced two thirds of a standard deviation score apart rather than the more usual unit spacing. This gives a set ofcurves very like the conventional 3rd to 97th centiles, but with additional curves at 2-67 standard deviation below and above the mean (roughly the 04th and 99-6th centiles). The 0-4th centile is a more practical cut off for screening purposes than the 3rd or 5th centile.
Growth charts are currently in the news. In Britain, the -long awaited successor to the Tanner-Whitehouse charts is starting to appear, and elsewhere an expert committee of the World Health Organisation has recently met to report on physical status: the use and interpretation of anthropometry. The remit of this committee is to review the evidence for using anthropometric charts at different stages of life and, where the evidence supports it, to suggest suitable charts.
It is an appropriate moment to question the way growth charts are designed. The chart's general form is a series of smooth curves representing selected centiles of the distribution of the measurement of interest (weight or height, usually) in the reference population, plotted against age. The actual centiles to be used on the chart have not been standardised.
There are essentially three schools of thought on the choice of centiles, most conveniently called the European, North American, and World Health Organisation schools. All agree that the centiles should be symmetrical above and below the median (50th centile) curve, but there the consensus ends. In Europe the 3rd, 10th, and 25th centiles are used below the median and the 75th, 90th and 97th above.1 2 Figure 1 shows the new British girls' height chart for 5 to 18 years.
In North America, the National Center for Health Statistics chart uses the 5th and 95th centiles instead of the 3rd and 97th,' whereas the World Health Organisation's international reference doesn't use centiles at all. 4 Instead it uses standard deviation scores (SDS; also known as z scores), which can be converted to centiles if the measurement is normally distributed (see fig 2) . The World Health Organisation curves are set at -3, -2 and -1 SD score below the median and 1, 2 and 3 SD score above, corresponding to the 0 14th, 2-3rd, 16th, 84th, 97-7th and 99-86th centiles respectively.
The 3rd through to the 97th centiles were originally chosen to be approximately equally spaced in terms of the standard deviation score, about 0-65 SD score apart.5 This is a useful property, common to both the European and World Health Organisation formats. It has the unfortunate side effect, though, that the two charts can be confused if the centile curves are unlabelled. A child on the 3rd centile is very different from one on the 0414th.
The three different approaches to choice of centile are due at least in part to differing requirements. In Europe and North America, the vast majority (notionally 94%) of children lie between the 3rd and 97th centiles, whereas in the developing world, where the World Health Organisation reference is used, many children lie below the 1st centile, which makes a classification based on centiles useless.
The American National Center for Health Statistics chart uses the 5th rather than the 3rd centile because the original compilers felt that the 3rd centile was too extreme to estimate accurately. However, this is no longer a valid argument. With large samples and improved statistical methods67 it is straightforward to estimate centiles down to the 3rd or lower. This applies both to height, which is normally distributed, and to non-normal measurements such as weight. The estimation process does not, however, extend to -3 SD score, as by definition only 0.14% of the reference .97th In practice there is no need for three different formats of growth chart-far better to use a common format worldwide. The crucial requirement is the -2 SD score curve, which is close to the 3rd centile. Curves similar to the 10th and 25th centiles can be achieved by using -1-33 SD score and -0-67 SD score, corresponding to the 9th and 25th centiles. The centile curves are then equally spaced, two thirds of a standard deviation score apart, as shown marked with bullets in figure 2 .
The -1 SD score and -3 SD score curves of the World Health Organisation reference do not fit this scheme, but the -1 SD score curve is little used for classification and could be omitted. The -3 SD score curve could be retained as it is or it could be moved up to -2-67 SD score, equal to the 0-4th centile, which would maintain the two thirds SD score spacing. This would still be useful for classification in the developing world, and it would provide a chart with nine equally spaced centiles (assuming + 2 67 SD score is included for symmetry). Figure 3 shows how the girls' height chart (fig 1) would look.
The obvious clinical advantage ofthis type of chart is that the lowest two curves provide a decision region for referral. Patients below the -2 SD score line can be considered for referral (but in practice may well not be), whereas those below -2-67 SD score should definitely be referred. Only one normal child in 260 lies below the lower cut off, as against one in 44 for -2 SD score, so the false positive rate is realistically lQw. 
Sham treatment is not justified
We were final year medical students observing at the gynaecology outpatient clinic. The consultant was explaining to the anxious patient that all the investigations had given normal results. He assured her that he had found nothing wrong. Then he wrote out a prescription, instructing her to take one tablet twice daily for a month. They were multivitamins he explained to us. "But doctor," she asked, "if there is nothing wrong with me, why do I need to take tablets?" The consultant agreed and crossed out his prescription. The patient was now obviously reassured and she left.
I resolved not to forget the lessons of this episode. Firstly, I learnt the importance of listening to patients and deducing the real purpose of the consultation. I began to realise how often people merely wanted a careful examination, followed by a reliable and trustworthy explanation. They did not expect to be cured-not even to be treated.
Secondly, I was impressed by the consultant's quick reversal of his prescribing decision in response to the patient's misgivings. We had a precise and shrewd perception of our teachers. Some consultants were pompous and would never have reversed their decision. I learnt to mistrust such arrogance. Candid admission of the limits of my knowledge and of treatment possibilities, when necessary, was always readily accepted by patients.
But the most important lesson was that ordering a treatment which is known not to affect the condition is wrong. It wastes the patient's time and money and it wastes medical resources. But worse than that it gives the patient false expectations, leading to disappointment, followed by loss of confidence and trust.
I have encountered many patients whose conditions could not be reversed or affected to any marked extent. A careful assessment, followed by an honest unhurried explanation with reassurance, will always take longer than prescribing placebo treatment. If we have verified that there is nothing wrong sham treatment is not justified.
Generations of medical students have been educated to regard placebo treatment as legitimate. But 
